|
|
| Growth Factors (Blood And Tissue) |
|
| Table of Contents Published: 2008/10 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Growth Factors (Blood And Tissue) in Millions of US$. The major product segments analyzed are Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins), and Tissue Growth ... |
| Microplate Instrumentation & Supplies |
|
| Table of Contents Published: 2008/10 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Microplate Instrumentation & Supplies in Millions of US$. The major product segments analyzed are Microplate Readers (UV-Vis Spectrophotometer, Fluorometer, Luminometer, Scintillation Counter, & Multimode Rea ... |
| Monoclonal Antibody Based Products |
|
| Table of Contents Published: 2008/10 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Monoclonal Antibody Based Products in Millions of US$. The major product segments and application areas analyzed are Therapeutics, and Diagnostics, especially for cancer. The report provides separate comprehe ... |
| Organ and Tissue Transplantation and Alternatives |
|
| Table of Contents Published: 2008/10 Published by: BCC Research |
| This report offers forecasts by product segment from 2008 through 2013, including supporting analyses for projections. Product segments covered consist of solid organs (e.g., kidneys, liver, heart-lung, pancreas, intestines) and the tissue transplantation ... |
| Pre-clinical Stage Partnering Agreements in Biopharma |
|
| Table of Contents Published: 2008/10 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Pre-clinical Stage Partnering Agreements in Biopharma report detailed understanding and analysis of how and why companies enter pre-clinical stage licensing/business development and other forms of partnering arrangement. ... |
| Strategic Analysis of the European Immunoassay Market |
|
| Table of Contents Published: 2008/10 Published by: Frost & Sullivan |
| This research service analyses the market scenario for immunoassays in laboratory and POC setting for major seven European countries. It analyses the market trends, market landscape,competitive strategies along with market drivers,restraints and challenge ... |
| Who's Developing What in Drug Delivery? |
|
| Table of Contents Published: 2008/10 Published by: Espicom Business Intelligence |
| The importance of drug delivery technology grows ever more acute and commercial, and industry interest is continuing to build. The benefits to patients can be seen through improved medical outcomes, while the pharmaceutical industry is able to bring new p ... |
| Biomarkers: The Future of Next-Generation Drug R&D |
|
| Table of Contents Published: 2008/09 Published by: Takeda Pacific |
| This report analyzes the hot global market for biomarkers and related assays or tests used in drug R&D. The study reviews this dynamic market by looking at drug research and development spending trends, M&As, alliances, major diseases, applications, tools ... |
| Biotechnology |
|
| Table of Contents Published: 2008/09 Published by: Global Industry Analysts, Inc. |
| The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird' s eye view of the Biotechnology industry. Annotated with 26 fact, and data rich ... |
| Cancer Drug Resistance 2008 |
|
| Table of Contents Published: 2008/09 Published by: BioPharm Reports (Technology and Markets Ltd) |
| This new report includes i) A Global Resistance Map: a presentation and review of resistance mechanisms or resistance-associated changes at the gene, protein or functional level reported for currently approved cancer drugs, covering 60 general cancer drug ... |
| Discovery Stage Partnering Agreements in Biopharma |
|
| Table of Contents Published: 2008/09 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Discovery Stage Partnering Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companies. ... |
| European Biosimilars Market Outlook |
|
| Table of Contents Published: 2008/09 Published by: Frost & Sullivan |
| This research services provides a current and future outlook for the evolving biosimilars market in Europe. It includes an overview of the current situation in Europe, various issues surrounding biosimilars, key drivers, restraints and challenges facing m ... |
| Gene Silencing Dashboard: Series Two |
|
| Table of Contents Published: 2008/09 Published by: Percepta Associates Inc. |
| RNA interference continues to emerge as a integral tool used to study the physiological role of gene products in vivo. RNAi-based methods allow researchers to modulate and in many cases virtually eliminate expression of a gene of interest. Systems for del ... |
| Global Antivirals Market Analysis & Forecasts 2008-2023 |
|
| Table of Contents Published: 2008/09 Published by: Visiongain |
| Investors are turning their attention to antiviral drug discovery because there is a renewed recognition of the promising opportunities in this $20bn market. Twenty years from the inception of focused antiviral drug research, there are 8 blockbuster drugs ... |
| Microarray Markets |
|
| Table of Contents Published: 2008/09 Published by: Trimark Publications |
| A microarray is an arrangement of miniaturized test sites or spots on a surface. Each spot is usually no more than 250 micrometers in diameter and contains biological molecules--usually DNA or protein--which act as probes for a test sample applied to the ... |
| Molecular Diagnostics Markets |
|
| Table of Contents Published: 2008/09 Published by: Trimark Publications |
| The technologies that constitute molecular diagnostics-first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels-a ... |
| Stem Cells in Regenerative Medicine 2008 Market Report |
|
| Table of Contents Published: 2008/09 Published by: Select Biosciences, Ltd. |
| This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences. This report focuses on the worldwide Regenerative Medicine/Cellular Therapy Marketplace which is a major segment of the overall stem cells space. ... |
| U.S. Nucleic Acid Purification and Isolation Markets |
|
| Table of Contents Published: 2008/09 Published by: Frost & Sullivan |
| This research service analyzes the market for nucleic acid purification and isolation products within the United States. The market was divided into the nucleic acid purification and isolation consumables and nucleic acid purification and isolation instru ... |
| U.S. Stem Cell Market - Current Developments |
|
| Table of Contents Published: 2008/09 Published by: Frost & Sullivan |
| This research service covers the U.S. stem cell market: current developments. Included are a disease overviews for main indications, estimated patient penetration for main indications, technology trends,and total market potential. The market is segmented ... |
| Who's Developing What in Global Biopharmaceuticals? |
|
| Table of Contents Published: 2008/09 Published by: Espicom Business Intelligence |
| The biopharmaceutical R&D sector is taking an ever more important role in the minds of industry and investors. The potential to fundamentally alter treatment regimes and cure, rather than symptomatically treat, many life-threatening conditions grows great ... |
| Biosimilars Series: Stakeholder Analysis |
|
| Table of Contents Published: 2008/08 Published by: Datamonitor |
| Although Europe is leading the way, the biosimilar industry is very much in its infancy, with the perception of key decision makers critical to the initial rate of uptake. The opinion of key stakeholders, and the influence they wield, will therefore infor ... |
| Cancer Biomarkers Players, products and prospects |
|
| Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence |
| The cancer biomarker market represents one of the largest segments of biomarkers in terms of revenue. In 2007, the estimated cancer biomarker market accounted for around 55% of biomarker revenues at over US$3 billion, with the majority of revenues derived ... |
| CNS Biomarkers Players, products and prospects |
|
| Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence |
| The CNS biomarker market represents one of the smallest segments of biomarkers in terms of revenue as relatively few CNS biomarkers are commercially available. In 2007, we estimate the CNS biomarker market accounted for less than 5% of biomarker revenues, ... |
| DNA Sequencing: Emerging Technologies and Applications |
|
| Table of Contents Published: 2008/08 Published by: BCC Research |
| The study scope includes DNA sequencing technologies likely to be commercialized within the next five years. Sanger and next generation (non-Sanger sequencing) technologies are included. Each technology is analyzed to determine its market status, impact o ... |
| Global Biotech Market Analysis and Forecasts, 2008-2023 |
|
| Table of Contents Published: 2008/08 Published by: Visiongain |
| The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has ... |
|
|
Top
View Cart
